UK markets closed

PCI Biotech Holding ASA (PCIBO.XC)

Cboe UK - Cboe UK Real-time price. Currency in NOK
Add to watchlist
2.0000+0.0020 (+0.10%)
At close: 11:49AM BST
Currency in NOK

Valuation measures4

Market cap (intra-day) 70.40M
Enterprise value 29.92M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.13
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.16

Trading information

Stock price history

Beta (5Y monthly) 1.70
52-week change 30.00%
S&P500 52-week change 326.24%
52-week high 32.0000
52-week low 31.9200
50-day moving average 31.9200
200-day moving average 31.9200

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 537.33M
Implied shares outstanding 650.35M
Float 829.86M
% held by insiders 123.95%
% held by institutions 18.29%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-370.62%

Management effectiveness

Return on assets (ttm)-25.85%
Return on equity (ttm)-42.13%

Income statement

Revenue (ttm)2.99M
Revenue per share (ttm)0.08
Quarterly revenue growth (yoy)8.40%
Gross profit (ttm)N/A
EBITDA -22.22M
Net income avi to common (ttm)-20.32M
Diluted EPS (ttm)-2.5500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)41.18M
Total cash per share (mrq)1.1
Total debt (mrq)319k
Total debt/equity (mrq)0.82%
Current ratio (mrq)8.80
Book value per share (mrq)1.05

Cash flow statement

Operating cash flow (ttm)-14.97M
Levered free cash flow (ttm)-8.73M